tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
US Market
VRTX
Vertex Pharmaceuticals
Overview
Analyst Forecasts
AI Stock Analysis
News & Insights
Financials
Dividends
Technical Analysis
Options
Chart
Earnings
Ownership
Stock Buybacks
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Vertex Pharmaceuticals (VRTX) Stock News & Sentiment

Compare
5,979 Followers
Vertex Pharmaceuticals: Buy Rating Driven by Outpatient Market Potential and Strategic Initiatives for Journavx
Premium
Ratings
Vertex Pharmaceuticals: Buy Rating Driven by Outpatient Market Potential and Strategic Initiatives for Journavx
1d ago
VRTX
Cautious Hold on Vertex Pharmaceuticals Amid Early-Stage Uncertainty of VX-522 Development
Premium
Ratings
Cautious Hold on Vertex Pharmaceuticals Amid Early-Stage Uncertainty of VX-522 Development
10d ago
VRTX
Q4 Earnings Surprise Greenlights CRISPR Therapeutics Stock Climb
Premium
Market News
Q4 Earnings Surprise Greenlights CRISPR Therapeutics Stock Climb
21d ago
CRSP
MRNA
Vertex Pharmaceuticals: Strong Financial Performance and Promising Future Prospects Reinforce Buy Rating
Premium
Ratings
Vertex Pharmaceuticals: Strong Financial Performance and Promising Future Prospects Reinforce Buy Rating
21d ago
VRTX
Cautious Outlook on Vertex Pharmaceuticals: Hold Rating Amid Growth Concerns and Premium Valuation
Premium
Ratings
Cautious Outlook on Vertex Pharmaceuticals: Hold Rating Amid Growth Concerns and Premium Valuation
22d ago
VRTX
Vertex Pharmaceuticals Reports Strong Revenue Growth Amid Challenges
Premium
Company Announcements
Vertex Pharmaceuticals Reports Strong Revenue Growth Amid Challenges
23d ago
VRTX
Vertex Pharmaceuticals’ Journavx: Strategic Market Adoption and Growth Outlook
Premium
Ratings
Vertex Pharmaceuticals’ Journavx: Strategic Market Adoption and Growth Outlook
23d ago
VRTX
More VRTX News >

VRTX News on the Web

Vertex Pharmaceuticals Stock: Is VRTX Outperforming the Healthcare Sector?
Barchart
Neutral
Vertex price experiences rapid rise in trading volumes - Forecast today - 03-03-2025
Economies.com
Bullish
Insider Sell: Ourania Tatsis Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus News
Neutral
Insider Sell: David Altshuler Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus News
Neutral
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
Zacks
Neutral
Should You Invest in the VanEck Biotech ETF (BBH)?
Zacks
Neutral
Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market
Pharmaceutical Technology
Neutral
Vertex's FDA Win: A Billion-Dollar Bet on Safer Pain Treatment
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
VRTX
Sector Average
Media Buzz
This Week4 articles
Weekly Average12.75 articles
News Sentiment
This Week100%
Sector Average54%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VRTX’s Media Buzz Sentiment?
4 articles about VRTX were published this week. In an average week, 12.75 articles are published.
    What is VRTX’s weekly average amount of articles?
    In an average week, 12.75 articles about VRTX are published.
      What is VRTX’s News Sentiment?
      100% of articles about VRTX were positive this week, compared to its sector average of 54%.
        Healthcare Stocks that are Trending in the News
        JAZZJazz Pharmaceuticals
        BTAIBioxcel Therapeutics
        CMPCompumedics Limited
        MASIMasimo
        OPCHOption Care Health
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing